# FDA Inspection 1232186 - Zimmer US, Inc - March 05, 2024

Source: https://www.keypedia.com/records/fda_inspections/zimmer-us-inc/96c56a7d-32b5-4ea0-8d7f-c6e8e2bffaea
Source feed: FDA_Inspections

> FDA Inspection 1232186 for Zimmer US, Inc on March 05, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1232186
- Company Name: Zimmer US, Inc
- Inspection Date: 2024-03-05
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122833 - 2020-03-02](https://www.keypedia.com/records/fda_inspections/zimmer-us-inc/56dc091f-a220-454f-8d05-a21d02cfa0ed)
- [FDA Inspection 1122833 - 2020-03-02](https://www.keypedia.com/records/fda_inspections/zimmer-us-inc/7eaf7c99-a441-4ad7-874b-7841cad68ad2)
- [FDA Inspection 1034338 - 2017-10-30](https://www.keypedia.com/records/fda_inspections/zimmer-us-inc/4d738a07-f99c-4033-82e9-a1e61d4f1574)
- [FDA Inspection 911605 - 2015-01-27](https://www.keypedia.com/records/fda_inspections/zimmer-us-inc/399eac5b-8b00-415d-a380-3607ad2e6ecd)

Company: https://www.keypedia.com/companies/zimmer-us-inc/a60fc9d4-9a7e-4865-bf86-bdadc479d6d4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d